Bristol-Myers immunotherapy combo promising in melanoma-study
April 20, 2015 at 08:30 AM EDT
April 20 (Reuters) - A combination of two Bristol-Myers Squibb drugs that help the immune system fight melanoma led to significantly greater tumor shrinkage than treatment with one of the medicines, according to a midstage study presented on Monday.